Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · IEX Real-Time Price · USD
6.19
+0.35 (5.99%)
At close: May 1, 2024, 1:54 PM
5.96
-0.23 (-3.72%)
After-hours: May 1, 2024, 4:00 PM EDT

Nanobiotix Revenue

In the year 2023, Nanobiotix had annual revenue of $40.23M with 691.80% growth.

Revenue (ttm)
$40.23M
Revenue Growth
+691.80%
P/S Ratio
6.89
Revenue / Employee
$394,412
Employees
102
Market Cap
273.62M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202340.23M35.15M691.80%
Dec 31, 20225.08M2.07M68.91%
Dec 31, 20213.01M-55.46K-1.81%
Dec 31, 20203.06M208.36K7.30%
Dec 31, 20192.86M-1.14M-28.60%
Dec 31, 20184.00M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Akebia Therapeutics 194.62M
Xeris Biopharma Holdings 163.91M
Sutro Biopharma 153.73M
ChromaDex 83.57M
EDAP TMS 67.14M
Metagenomi 44.76M
Revenue Rankings